Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Lückel, Christina
Diğer Yazarlar: Huber, Magdalena (Prof. Dr.) (Tez danışmanı)
Materyal Türü: Dissertation
Dil:İngilizce
Baskı/Yayın Bilgisi: Philipps-Universität Marburg 2018
Konular:
multiple sclerosis
IL-17
Multiple Sklerose
ROS
Tc17 cells
Dimethyl fumarate
Tc17 Zellen
Dimethylfumarat
Medizin
Medical sciences Medicine
Online Erişim:PDF Tam Metin
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

PDF Tam Metin

Detaylı Erişim Bilgileri
Yer Numarası: urn:nbn:de:hebis:04-z2018-03301
Yayın Tarihi: 2019-02-28
Datum der Annahme: 2018-08-15
Downloads: 45 (2024), 86 (2023), 69 (2022), 72 (2021), 76 (2020), 69 (2019)
Lizenz: https://creativecommons.org/licenses/by-nc-sa/4.0
Erişim Adresi URL: https://archiv.ub.uni-marburg.de/diss/z2018/0330
https://doi.org/10.17192/z2018.0330

Benzer Materyaller